Article(id=1329914917202801546, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914828526826294, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2024.05.004, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1704124800000, receivedDateStr=2024-01-02, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795006024884, onlineDateStr=2026-11-18, pubDate=1715270400000, pubDateStr=2024-05-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795006024884, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795006024884, creator=13701087609, updateTime=1795006024884, updator=13701087609, issue=Issue{id=1329914828526826294, tenantId=1146029695717560320, journalId=1319690259887390882, year='2024', volume='55', issue='5', pageStart='593', pageEnd='742', issueExtLink='null', onlineDate='null', pubDate='1715270400000', pubDateStr='2024-05-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795006003743, creator='13701087609', updateTime=1795136133419, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330460632421348098, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914828526826294, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330460632421348099, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914828526826294, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=620, endPage=628, ext={EN=ArticleExt(id=1329914917387350923, articleId=1329914917202801546, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=The Application Development of Organoids for Drug Evaluation, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

In recent years, organoids and organ chips have been developed rapidly. Organoids show certain advantages such as physiological, human origin, genetic stability, high throughput and easy operation, and can be widely used in many fields including drug development, drug evaluation and regenerative medicine. The application of organoids to drug developing include the evaluation of pharmacodynamics, pharmacokinetics, effectiveness and safety, especially for non-clinical pharmacodynamic evaluation. Here, the applications of organoids and their representative models in drug evaluation are introduced, the regulatory international regulatory policy and industry developments are briefly reviewed. Finally, the applications and challenges of organoids and organ chips for non-clinical alternative or complementary models are discussed.

, authors=Wenbin DONG1, Hui LI2, Yifei CHEN3, *, authorsList=Wenbin DONG, Hui LI, Yifei CHEN, authorCompany=null, correspAuthors=Yifei CHEN, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329914918238794636, articleId=1329914917202801546, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=类器官技术在药物评价中的应用进展, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

近年来类器官和器官芯片技术发展迅速。类器官具有近生理性、人源性、遗传稳定性、高通量、易操作等优势,与器官芯片技术结合,可广泛应用于药物开发、药物评价、再生医疗等多个领域。类器官技术在药物评价中的应用包括药效动力学、药物代谢动力学、药物有效性和安全性等,其中在非临床药效学评价中的应用发展较快。文章介绍了类器官技术及其代表性模型在药物评价中的应用,综述了国际监管政策和行业发展现状,简介了应用案例,并对类器官和器官芯片技术用于非临床替代或补充模型的应用和挑战进行了讨论。

, authors=董文彬1, 李慧2, 陈一飞3, *, authorsList=董文彬, 李慧, 陈一飞, authorCompany=null, correspAuthors=陈一飞, authorNote=

董文彬(1997—),女,硕士研究生,专业方向:新药研究与开发。

, correspAuthorsNote=
陈一飞(1983—),女,副研究员,从事GCP/GLP、药品监管科学的研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=fVxM9320ar8zVc4XUW/dMQ==, magXml=i+CTzA4UB6YMLAopz1yEGQ==, pdfUrl=null, pdf=3P/YL/oFztwvuigrVf/liA==, pdfFileSize=1859776, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=keRLR3dbGJMiSj/5oeMdqA==, mapNumber=null, fund=null)}, authors=[Author(id=1329914918737916823, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914918821802905, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, authorId=1329914918737916823, language=EN, stringName=Wenbin DONG, firstName=Wenbin, middleName=null, lastName=DONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of Pharmacy, Fudan University, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914918893106074, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, authorId=1329914918737916823, language=CN, stringName=董文彬, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.复旦大学药学院,上海 201203, bio={"content":"

董文彬(1997—),女,硕士研究生,专业方向:新药研究与开发。

"}, bioImg=null, bioContent=

董文彬(1997—),女,硕士研究生,专业方向:新药研究与开发。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914918461092749, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, xref=1., ext=[AuthorCompanyExt(id=1329914918469481358, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, companyId=1329914918461092749, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1329914918477869967, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, companyId=1329914918461092749, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学药学院,上海 201203)])]), Author(id=1329914918964409244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914919044101022, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, authorId=1329914918964409244, language=EN, stringName=Hui LI, firstName=Hui, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Zhongshan Hospital, Fudan University, Shanghai 200032, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914919107015583, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, authorId=1329914918964409244, language=CN, stringName=李慧, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.复旦大学附属中山医院,上海 200032, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914918561756048, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, xref=2., ext=[AuthorCompanyExt(id=1329914918570144657, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, companyId=1329914918561756048, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Zhongshan Hospital, Fudan University, Shanghai 200032), AuthorCompanyExt(id=1329914918582727570, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, companyId=1329914918561756048, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学附属中山医院,上海 200032)])]), Author(id=1329914919178318753, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=chenyifei25@smda.sh.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914919262204835, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, authorId=1329914919178318753, language=EN, stringName=Yifei CHEN, firstName=Yifei, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914919333508004, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, authorId=1329914919178318753, language=CN, stringName=陈一飞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.上海药品审评核查中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914918654030739, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, xref=3., ext=[AuthorCompanyExt(id=1329914918666613652, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, companyId=1329914918654030739, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203), AuthorCompanyExt(id=1329914918679196565, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, companyId=1329914918654030739, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海药品审评核查中心,上海 201203)])])], keywords=[Keyword(id=1329914919438365605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, language=EN, orderNo=1, keyword=organoid), Keyword(id=1329914919526445990, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, language=EN, orderNo=2, keyword=organ chip), Keyword(id=1329914919601943463, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, language=EN, orderNo=3, keyword=drug evaluation), Keyword(id=1329914919673246632, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, language=EN, orderNo=4, keyword=non-clinical pharmacodynamic evaluation), Keyword(id=1329914919752938410, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, language=EN, orderNo=5, keyword=research progress), Keyword(id=1329914919849407403, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, language=CN, orderNo=1, keyword=类器官), Keyword(id=1329914919929099180, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, language=CN, orderNo=2, keyword=器官芯片), Keyword(id=1329914919987819437, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, language=CN, orderNo=3, keyword=药物评价), Keyword(id=1329914920042345390, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, language=CN, orderNo=4, keyword=非临床药效学评价), Keyword(id=1329914920113648559, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, language=CN, orderNo=5, keyword=研究进展)], refs=[Reference(id=1329914920218506160, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH.ICH M3(R2): Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals [EB/OL].(2009-06-11)[2024-04-16].https://database.ich.org/sites/default/files/M3_R2__Guideline.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914920285615025, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=YOUHANNA S, KEMAS A M, PREISS L, et al.Organotypic and microphysiological human tissue models for drug discovery and development-current state-of-the-art and future perspectives [J].Pharmacol Rev, 2022, 74(1): 141-206., articleTitle=null, refAbstract=null), Reference(id=1329914920352723890, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=莫少波,管若羽,张龙,等.类器官在临床医学中的应用和研究进展[J].中国科学:生命科学,2023,53(2):221-237., articleTitle=null, refAbstract=null), Reference(id=1329914920507913139, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=张文庆,王璇璇,黄安琪,等.器官芯片技术在药物毒理学领域的研究现状及应用前景[J].世界临床药物,2023,44(1):83-89., articleTitle=null, refAbstract=null), Reference(id=1329914920604382132, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=陈晔光,赵联正.中国类器官研究的发展[J].中国科学:生命科学,2023,53(2):137-139., articleTitle=null, refAbstract=null), Reference(id=1329914920696656821, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=SATO T, VRIES R G, SNIPPERT H J, et al.Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche [J].Nature, 2009, 459(7244): 262-265., articleTitle=null, refAbstract=null), Reference(id=1329914920839263158, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=CORRÒ C, NOVELLASDEMUNT L, LI V S W.A brief history of organoids [J].Am J Physiol Cell Physiol, 2020, 319(1): C151-C165., articleTitle=null, refAbstract=null), Reference(id=1329914920914760631, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=王亚清,陶婷婷,秦建华.类器官芯片[J].中国科学:生命科学,2023,53(2):211-220., articleTitle=null, refAbstract=null), Reference(id=1329914920986063800, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=LI M, IZPISUA BELMONTE J C.Organoids - preclinical models of human disease [J].N Engl J Med, 2019, 380(6): 569-579., articleTitle=null, refAbstract=null), Reference(id=1329914921074144185, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=National Center for Advancing Translation Sciences.Tissue chip initiatives & projects [EB/OL].(2023-04-28)[2024-04-16].https://ncats.nih.gov/tissuechip/projects., articleTitle=null, refAbstract=null), Reference(id=1329914921141253050, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.FDA’s predictive toxicology roadmap [EB/OL].(2020-09-25)[2024-04-16].https://www.fda.gov/science-research/about-science-research-fda/fdas-predictive-toxicology-roadmap., articleTitle=null, refAbstract=null), Reference(id=1329914921204167611, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Advancing alternative methods at FDA [EB/OL].(2022-01-05)[2024-04-16].https://www.fda.gov/science-research/about-science-research-fda/advancing-alternative-methods-fda., articleTitle=null, refAbstract=null), Reference(id=1329914921279665084, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=ADASHI E Y, O’MAHONY D P, COHEN I G.The FDA Modernization Act 2.0: drug testing in animals is rendered optional [J/OL].Am J Med, 2023, 136(9): 853-854., articleTitle=null, refAbstract=null), Reference(id=1329914921367745469, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=EPA.Directive to prioritize efforts to reduce animal testing [EB/OL].(2019-09-10)[2024-04-16].https://www.epa.gov/sites/default/files/2019-09/documents/image2019-09-09-231249.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914921434854334, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.First EMA workshop on non-animal approaches in support of medicinal product development: challenges and opportunities for use of micro-physiological systems [EB/OL].(2017-05-10)[2024-04-16].https://www.ema.europa.eu/en/documents/report/report-first-ema-workshop-non-animal-approaches-support-medicinal-product-development-challenges_en.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914921497768895, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=PAMIES D, LEIST M, COECKE S, et al.Guidance document on Good Cell and Tissue Culture Practice 2.0(GCCP 2.0) [J].ALTEX, 2022, 39: 30-70., articleTitle=null, refAbstract=null), Reference(id=1329914921564877760, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=HCA.New EU-funded Research Project “HCA|Organoid”: toward a single-cell atlas of human organoids for biomedical research [EB/OL].(2020-08-31)[2024-04-16].https://www.hca-organoid.eu/news/kickstarting-organoid-cell-atlas., articleTitle=null, refAbstract=null), Reference(id=1329914921627792321, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=European Commission.Horizon Europe Health double stage calls 2024 - Unlocking the full potential of new tools, technologies and digital solutions for a healthy society(Destination 5)[EB/OL].(2023-03-30)[2024-04-16].https://hadea.ec.europa.eu/calls-proposals/horizon-europe-health-double-stage-calls-2024-unlocking-full-potential-new-tools-technologies-and_en., articleTitle=null, refAbstract=null), Reference(id=1329914921690706882, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=MARX U, AKABANE T, ANDERSSON T B, et al.Biologyinspired microphysiological systems to advance patient benefit and animal welfare in drug development [J].ALTEX, 2020, 37(3): 365-394., articleTitle=null, refAbstract=null), Reference(id=1329914921762010051, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=国家科学技术部.科技部关于发布国家重点研发计划“数学和应用研究”等“十四五”重点专项2021年度项目申报指南的通知[EB/OL].(2021-05-10)[2024-04-16].https://service.most.gov.cn/kjjh_tztg_all/20210510/4272.html., articleTitle=null, refAbstract=null), Reference(id=1329914921837507524, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.基因治疗产品非临床研究与评价技术指导原则(试行)[EB/OL].(2021-12-03)[2024-04-16].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=3c3eef7964f7950ca9a18b-9ce095088c., articleTitle=null, refAbstract=null), Reference(id=1329914921933976517, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.基因修饰细胞治疗产品非临床研究技术指导原则(试行)[EB/OL].(2021-12-03)[2024-04-16].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=b7dfbba537d5ecc30659d-715f5045acb., articleTitle=null, refAbstract=null), Reference(id=1329914921996891078, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=类器官药物敏感性检测指导肿瘤精准治疗临床应用专家共识(2022年版)编写专家组,王树滨,高静,等.类器官药物敏感性检测指导肿瘤精准治疗临床应用专家共识(2022年版)[J].中国癌症防治杂志,2022,14(3):234-239., articleTitle=null, refAbstract=null), Reference(id=1329914922051417031, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=中国抗癌协会肿瘤多学科诊疗专业委员会,中国抗癌协会肿瘤内分泌专业委员会,邹冬玲,等.肿瘤类器官诊治平台的质量控制标准中国专家共识(2022年版)[J].中国癌症杂志,2022,32(7):657-668., articleTitle=null, refAbstract=null), Reference(id=1329914922110137288, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=中国细胞生物学学会.人肠癌类器官[EB/OL].(2022-09-23)[2024-04-16].http://www.ttbz.org.cn/StandardManage/Detail/67886/., articleTitle=null, refAbstract=null), Reference(id=1329914922164663241, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=中国细胞生物学学会.人肠道类器官[EB/OL].(2022-09-23)[2024-04-16].http://www.ttbz.org.cn/StandardManage/Detail/67884/., articleTitle=null, refAbstract=null), Reference(id=1329914922227577802, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=中国医药生物技术协会.人正常乳腺及乳腺癌类器官制备、冻存、复苏和鉴定操作指南[EB/OL].(2023-02-22)[2024-04-16].http://www.ttbz.org.cn/StandardManage/Detail/77610/., articleTitle=null, refAbstract=null), Reference(id=1329914922290492363, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=XU R, ZHOU X, WANG S, et al.Tumor organoid models in precision medicine and investigating cancer-stromal interactions [J].Pharmacol Ther, 2021, 218: 107668., articleTitle=null, refAbstract=null), Reference(id=1329914922353406924, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU H, ZHANG Y, ZHANG Y Y, et al.Human embryonic stem cell-derived organoid retinoblastoma reveals a cancerous origin [J].Proc Natl Acad Sci U S A, 2020, 117(52): 33628-33638., articleTitle=null, refAbstract=null), Reference(id=1329914922412127181, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=CANDIELLO J, GRANDHI T S P, GOH S K, et al.3D heterogeneous islet organoid generation from human embryonic stem cells using a novel engineered hydrogel platform [J].Biomaterials, 2018, 177: 27-39., articleTitle=null, refAbstract=null), Reference(id=1329914922475041742, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=VARZIDEH F, PAHLAVAN S, ANSARI H, et al.Human cardiomyocytes undergo enhanced maturation in embryonic stem cell-derived organoid transplants [J].Biomaterials, 2019, 192: 537-550., articleTitle=null, refAbstract=null), Reference(id=1329914922533761999, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=RAHMANI S, BREYNER N M, SU H M, et al.Intestinal organoids: a new paradigm for engineering intestinal epithelium in vitro [J].Biomaterials, 2019, 194: 195-214., articleTitle=null, refAbstract=null), Reference(id=1329914922592482256, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=BAYRER J R, WANG H, NATTIV R, et al.LRH-1 mitigates intestinal inflammatory disease by maintaining epithelial homeostasis and cell survival [J].Nat Commun, 2018, 9(1): 4055., articleTitle=null, refAbstract=null), Reference(id=1329914922651202513, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=MARTÍNEZ-SÁNCHEZ L D C, NGO P A, PRADHAN R,et al.Epithelial RAC1-dependent cytoskeleton dynamics controls cell mechanics, cell shedding and barrier integrity in intestinal inflammation [J].Gut, 2023, 72(2): 275-294., articleTitle=null, refAbstract=null), Reference(id=1329914922705728466, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=ZUO L, KUO WT, CAO F, et al.Tacrolimus-binding protein FKBP8 directs myosin light chain kinase-dependent barrier regulation and is a potential therapeutic target in Crohn’s disease [J].Gut, 2023, 72(5): 870-881., articleTitle=null, refAbstract=null), Reference(id=1329914922781225939, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=MITHAL A, CAPILLA A, HEINZE D, et al.Generation of mesenchyme free intestinal organoids from human induced pluripotent stem cells [J].Nat Commun, 2020, 11(1): 215., articleTitle=null, refAbstract=null), Reference(id=1329914922839946196, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=LEE H, JUNG K B, KWON O, et al.Limosilactobacillus reuteri DS0384 promotes intestinal epithelial maturation via the postbiotic effect in human intestinal organoids and infant mice [J].Gut Microbes, 2022, 14(1): 2121580., articleTitle=null, refAbstract=null), Reference(id=1329914922902860757, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=LULLA V, DINAN A M, HOSMILLO M, et al.An upstream protein-coding region in enteroviruses modulates virus infection in gut epithelial cells [J].Nat Microbiol, 2019, 4(2): 280-292., articleTitle=null, refAbstract=null), Reference(id=1329914922957386710, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=LIN S C, HAGA K, ZENG X L, et al.Generation of CRISPR-Cas9-mediated genetic knockout human intestinal tissue-derived enteroid lines by lentivirus transduction and single-cell cloning [J].Nat Protoc, 2022, 17(4): 1004-1027., articleTitle=null, refAbstract=null), Reference(id=1329914923016106967, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=DROST J, VAN BOXTEL R, BLOKZIJL F, et al.Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer [J].Science, 2017, 358(6360): 234-238., articleTitle=null, refAbstract=null), Reference(id=1329914923074827224, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=MATANO M, DATE S, SHIMOKAWA M, et al.Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids [J].Nat Med, 2015, 21(3): 256-262., articleTitle=null, refAbstract=null), Reference(id=1329914923141936089, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=MEAD B E, HATTORI K, LEVY L, et al.Screening for modulators of the cellular composition of gut epithelia via organoid models of intestinal stem cell differentiation [J].Nat Biomed Eng, 2022, 6(4): 476-494., articleTitle=null, refAbstract=null), Reference(id=1329914923209044954, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=CRUZ-ACUÑA R, QUIRÓS M, FARKAS A E, et al.Synthetic hydrogels for human intestinal organoid generation and colonic wound repair [J].Nat Cell Biol, 2017, 19(11): 1326-1335., articleTitle=null, refAbstract=null), Reference(id=1329914923280348123, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=JARDI F, KELLY C, TEAGUE C, et al.Mouse organoids as an in vitro tool to study the in vivo intestinal response to cytotoxicants [J].Arch Toxicol, 2023, 97(1): 235-254., articleTitle=null, refAbstract=null), Reference(id=1329914923351651292, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=SUGIMOTO S, KOBAYASHI E, FUJII M, et al.An organoid-based organ-repurposing approach to treat short bowel syndrome [J].Nature, 2021, 592(7852): 99-104., articleTitle=null, refAbstract=null), Reference(id=1329914923418760157, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=RUMSEY J W, LORANCE C, JACKSON M, et al.Classical complement pathway inhibition in a “human-on-a-chip” model of autoimmune demyelinating neuropathies [J].Adv Ther(Weinh), 2022, 5(6): 2200030., articleTitle=null, refAbstract=null), Reference(id=1329914923481674718, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=SEO Y, BANG S, SON J, et al.Brain physiome: a concept bridging in vitro 3D brain models and in silico models for predicting drug toxicity in the brain [J].Bioact Mater, 2021, 13: 135-148., articleTitle=null, refAbstract=null), Reference(id=1329914923557172191, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=TAN H Y, CHO H, LEE L P.Human mini-brain models [J].Nat Biomed Eng, 2021, 5(1): 11-25., articleTitle=null, refAbstract=null), Reference(id=1329914923624281056, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=QIAN X, SONG H, MING G L.Brain organoids: advances, applications and challenges [J].Development, 2019, 146(8): dev166074., articleTitle=null, refAbstract=null), Reference(id=1329914923691389921, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=MA C, SEONG H, LI X, et al.Human brain organoid: a versatile tool for modeling neurodegeneration diseases and for drug screening [J].Stem Cells Int, 2022, 2022: 2150680., articleTitle=null, refAbstract=null), Reference(id=1329914923750110178, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=LESAVAGE B L, SUHAR R A, BROGUIERE N, et al.Next-generation cancer organoids [J].Nat Mater, 2022, 21(2): 143-159., articleTitle=null, refAbstract=null), Reference(id=1329914923825607651, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=XIANG Y, TANAKA Y, PATTERSON B, et al.Fusion of regionally specified hpsc-derived organoids models human brain development and interneuron migration [J].Cell Stem Cell, 2017, 21(3): 383-398., articleTitle=null, refAbstract=null), Reference(id=1329914923901105124, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=KIM H, KAMM R D, VUNJAK-NOVAKOVIC G, et al.Progress in multicellular human cardiac organoids for clinical applications [J].Cell Stem Cell, 2022, 29(4): 503-514., articleTitle=null, refAbstract=null), Reference(id=1329914923972408293, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=XUAN W, TIPPARAJU S M, ASHRAF M.Transformational applications of human cardiac organoids in cardiovascular diseases [J].Front Cell Dev Biol, 2022, 10: 936084., articleTitle=null, refAbstract=null), Reference(id=1329914924060488678, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[55], rfOrder=54, authorNames=null, journalName=null, refType=null, unstructuredReference=PRIOR N, INACIO P, HUCH M.Liver organoids: from basic research to therapeutic applications [J].Gut, 2019, 68(12): 2228-2237., articleTitle=null, refAbstract=null), Reference(id=1329914924127597543, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[56], rfOrder=55, authorNames=null, journalName=null, refType=null, unstructuredReference=BROOKS A, LIANG X, ZHANG Y, et al.Liver organoid as a 3D in vitro model for drug validation and toxicity assessment [J].Pharmacol Res, 2021, 169: 105608., articleTitle=null, refAbstract=null), Reference(id=1329914924203095016, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[57], rfOrder=56, authorNames=null, journalName=null, refType=null, unstructuredReference=LUO Z, ZHOU X, MANDAL K, et al.Reconstructing the tumor architecture into organoids [J].Adv Drug Deliv Rev, 2021, 176: 113839., articleTitle=null, refAbstract=null), Reference(id=1329914924261815273, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[58], rfOrder=57, authorNames=null, journalName=null, refType=null, unstructuredReference=VENINGA V, VOEST E E.Tumor organoids: opportunities and challenges to guide precision medicine [J].Cancer Cell, 2021, 39(9): 1190-1201., articleTitle=null, refAbstract=null), Reference(id=1329914924333118442, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[59], rfOrder=58, authorNames=null, journalName=null, refType=null, unstructuredReference=QU J, KALYANI F S, LIU L, et al.Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy [J].Cancer Commun (Lond),2021, 41(12): 1331-1353., articleTitle=null, refAbstract=null), Reference(id=1329914924400227307, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[60], rfOrder=59, authorNames=null, journalName=null, refType=null, unstructuredReference=LOW L A, MUMMERY C, BERRIDGE B R, et al.Organs-on-chips: into the next decade [J].Nat Rev Drug Discov, 2021, 20(5): 345-361., articleTitle=null, refAbstract=null), Reference(id=1329914924463141868, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[61], rfOrder=60, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Advancing alternative methods at FDA [EB/OL].(2022-01-05)[2024-04-16].https://www.fda.gov/science-research/about-science-research-fda/advancing-alternative-methods-fda., articleTitle=null, refAbstract=null), Reference(id=1329914924530250733, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[62], rfOrder=61, authorNames=null, journalName=null, refType=null, unstructuredReference=TANG X Y, WU S, WANG D, et al.Human organoids in basic research and clinical applications [J].Signal Transduct Target Ther, 2022, 7(1): 168., articleTitle=null, refAbstract=null), Reference(id=1329914924593165294, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[63], rfOrder=62, authorNames=null, journalName=null, refType=null, unstructuredReference=MUN S J, RYU J S, LEE M O, et al.Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids [J].J Hepatol, 2019, 71(5): 970-985., articleTitle=null, refAbstract=null), Reference(id=1329914924664468463, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[64], rfOrder=63, authorNames=null, journalName=null, refType=null, unstructuredReference=LOW J H, LI P, CHEW E G Y, et al.Generation of human PSC-derived kidney organoids with patterned nephron segments and a de novo vascular network [J].Cell Stem Cell, 2019, 25(3): 373-387., articleTitle=null, refAbstract=null), Reference(id=1329914924731577328, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[65], rfOrder=64, authorNames=null, journalName=null, refType=null, unstructuredReference=FERRARI E, RASPONI M.Liver-Heart on chip models for drug safety [J].APL Bioeng, 2021, 5(3): 031505., articleTitle=null, refAbstract=null), Reference(id=1329914924798686193, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[66], rfOrder=65, authorNames=null, journalName=null, refType=null, unstructuredReference=SIMMONS K T, CHAN J, HUSSAIN S, et al.Anti-C1s humanized monoclonal antibody SAR445088: a classical pathway complement inhibitor specific for the active form of C1s [J].Clin Immunol, 2023, 251: 109629., articleTitle=null, refAbstract=null), Reference(id=1329914924886766578, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[67], rfOrder=66, authorNames=null, journalName=null, refType=null, unstructuredReference=HESPEROS.Hesperos shows potential for in vitro approach to replace conventional animal efficacy studies for rare neuromuscular disorders [EB/OL].(2022-04-19)[2024-04-16].https://hesperosinc.com/efficacy-study-for-rare-neuromuscular-disorders/., articleTitle=null, refAbstract=null), Reference(id=1329914924979041267, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[68], rfOrder=67, authorNames=null, journalName=null, refType=null, unstructuredReference=ISOHERRANEN N, MADABUSHI R, HUANG S M.Emerging role of organ-on-a-chip technologies in quantitative clinical pharmacology evaluation [J].Clin Transl Sci, 2019, 12(2): 113-121., articleTitle=null, refAbstract=null), Reference(id=1329914925046150132, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[69], rfOrder=68, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG H, BROWN P C, CHOW E C Y, et al.3D cell culture models: drug pharmacokinetics, safety assessment, and regulatory consideration [J].Clin Transl Sci, 2021, 14(5): 1659-1680., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329914918461092749, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, xref=1., ext=[AuthorCompanyExt(id=1329914918469481358, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, companyId=1329914918461092749, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1329914918477869967, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, companyId=1329914918461092749, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学药学院,上海 201203)]), AuthorCompany(id=1329914918561756048, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, xref=2., ext=[AuthorCompanyExt(id=1329914918570144657, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, companyId=1329914918561756048, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Zhongshan Hospital, Fudan University, Shanghai 200032), AuthorCompanyExt(id=1329914918582727570, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, companyId=1329914918561756048, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学附属中山医院,上海 200032)]), AuthorCompany(id=1329914918654030739, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, xref=3., ext=[AuthorCompanyExt(id=1329914918666613652, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, companyId=1329914918654030739, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203), AuthorCompanyExt(id=1329914918679196565, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, companyId=1329914918654030739, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海药品审评核查中心,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.05.004, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.05.004, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2024.05.004, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2024.05.004, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1715270400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
类器官技术在药物评价中的应用进展
董文彬 1 , 李慧 2 , 陈一飞 3, *
中国医药工业杂志 | 综述 2024,55(5): 620-628
收起
收藏切换
中国医药工业杂志 |综述 2024 , 55 (5) : 620 -628
类器官技术在药物评价中的应用进展
全屏
[Author(id=1329914918737916823, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914918821802905, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, authorId=1329914918737916823, language=EN, stringName=Wenbin DONG, firstName=Wenbin, middleName=null, lastName=DONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of Pharmacy, Fudan University, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914918893106074, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, authorId=1329914918737916823, language=CN, stringName=董文彬, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.复旦大学药学院,上海 201203, bio={"content":"

董文彬(1997—),女,硕士研究生,专业方向:新药研究与开发。

"}, bioImg=null, bioContent=

董文彬(1997—),女,硕士研究生,专业方向:新药研究与开发。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914918461092749, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, xref=1., ext=[AuthorCompanyExt(id=1329914918469481358, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, companyId=1329914918461092749, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1329914918477869967, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, companyId=1329914918461092749, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学药学院,上海 201203)])]), Author(id=1329914918964409244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914919044101022, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, authorId=1329914918964409244, language=EN, stringName=Hui LI, firstName=Hui, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Zhongshan Hospital, Fudan University, Shanghai 200032, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914919107015583, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, authorId=1329914918964409244, language=CN, stringName=李慧, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.复旦大学附属中山医院,上海 200032, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914918561756048, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, xref=2., ext=[AuthorCompanyExt(id=1329914918570144657, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, companyId=1329914918561756048, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Zhongshan Hospital, Fudan University, Shanghai 200032), AuthorCompanyExt(id=1329914918582727570, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, companyId=1329914918561756048, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学附属中山医院,上海 200032)])]), Author(id=1329914919178318753, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=chenyifei25@smda.sh.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914919262204835, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, authorId=1329914919178318753, language=EN, stringName=Yifei CHEN, firstName=Yifei, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914919333508004, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, authorId=1329914919178318753, language=CN, stringName=陈一飞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.上海药品审评核查中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914918654030739, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, xref=3., ext=[AuthorCompanyExt(id=1329914918666613652, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, companyId=1329914918654030739, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203), AuthorCompanyExt(id=1329914918679196565, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914917202801546, companyId=1329914918654030739, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海药品审评核查中心,上海 201203)])])]
董文彬1, 李慧2, 陈一飞3, *
作者信息
  • 1.复旦大学药学院,上海 201203
  • 2.复旦大学附属中山医院,上海 200032
  • 3.上海药品审评核查中心,上海 201203
通讯作者:
陈一飞(1983—),女,副研究员,从事GCP/GLP、药品监管科学的研究。E-mail:
作者简介:

董文彬(1997—),女,硕士研究生,专业方向:新药研究与开发。

The Application Development of Organoids for Drug Evaluation
Wenbin DONG1, Hui LI2, Yifei CHEN3, *
Affiliations
  • 1.School of Pharmacy, Fudan University, Shanghai 201203
  • 2.Zhongshan Hospital, Fudan University, Shanghai 200032
  • 3.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203
出版时间: 2024-05-10 doi: 10.16522/j.cnki.cjph.2024.05.004
文章导航
收藏切换

近年来类器官和器官芯片技术发展迅速。类器官具有近生理性、人源性、遗传稳定性、高通量、易操作等优势,与器官芯片技术结合,可广泛应用于药物开发、药物评价、再生医疗等多个领域。类器官技术在药物评价中的应用包括药效动力学、药物代谢动力学、药物有效性和安全性等,其中在非临床药效学评价中的应用发展较快。文章介绍了类器官技术及其代表性模型在药物评价中的应用,综述了国际监管政策和行业发展现状,简介了应用案例,并对类器官和器官芯片技术用于非临床替代或补充模型的应用和挑战进行了讨论。

类器官  /  器官芯片  /  药物评价  /  非临床药效学评价  /  研究进展

In recent years, organoids and organ chips have been developed rapidly. Organoids show certain advantages such as physiological, human origin, genetic stability, high throughput and easy operation, and can be widely used in many fields including drug development, drug evaluation and regenerative medicine. The application of organoids to drug developing include the evaluation of pharmacodynamics, pharmacokinetics, effectiveness and safety, especially for non-clinical pharmacodynamic evaluation. Here, the applications of organoids and their representative models in drug evaluation are introduced, the regulatory international regulatory policy and industry developments are briefly reviewed. Finally, the applications and challenges of organoids and organ chips for non-clinical alternative or complementary models are discussed.

organoid  /  organ chip  /  drug evaluation  /  non-clinical pharmacodynamic evaluation  /  research progress
董文彬, 李慧, 陈一飞. 类器官技术在药物评价中的应用进展. 中国医药工业杂志, 2024 , 55 (5) : 620 -628 . DOI: 10.16522/j.cnki.cjph.2024.05.004
Wenbin DONG, Hui LI, Yifei CHEN. The Application Development of Organoids for Drug Evaluation[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (5) : 620 -628 . DOI: 10.16522/j.cnki.cjph.2024.05.004

参考文献 引证文献
排序方式:
[1]
ICH.ICH M3(R2): Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals [EB/OL].(2009-06-11)[2024-04-16].https://database.ich.org/sites/default/files/M3_R2__Guideline.pdf.
[2]
YOUHANNA S, KEMAS A M, PREISS L, et al.Organotypic and microphysiological human tissue models for drug discovery and development-current state-of-the-art and future perspectives [J].Pharmacol Rev, 2022, 74(1): 141-206.
[3]
莫少波,管若羽,张龙,等.类器官在临床医学中的应用和研究进展[J].中国科学:生命科学,2023,53(2):221-237.
[4]
张文庆,王璇璇,黄安琪,等.器官芯片技术在药物毒理学领域的研究现状及应用前景[J].世界临床药物,2023,44(1):83-89.
[5]
陈晔光,赵联正.中国类器官研究的发展[J].中国科学:生命科学,2023,53(2):137-139.
[6]
SATO T, VRIES R G, SNIPPERT H J, et al.Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche [J].Nature, 2009, 459(7244): 262-265.
[7]
CORRÒ C, NOVELLASDEMUNT L, LI V S W.A brief history of organoids [J].Am J Physiol Cell Physiol, 2020, 319(1): C151-C165.
[8]
王亚清,陶婷婷,秦建华.类器官芯片[J].中国科学:生命科学,2023,53(2):211-220.
[9]
LI M, IZPISUA BELMONTE J C.Organoids - preclinical models of human disease [J].N Engl J Med, 2019, 380(6): 569-579.
[10]
National Center for Advancing Translation Sciences.Tissue chip initiatives & projects [EB/OL].(2023-04-28)[2024-04-16].https://ncats.nih.gov/tissuechip/projects.
[11]
FDA.FDA’s predictive toxicology roadmap [EB/OL].(2020-09-25)[2024-04-16].https://www.fda.gov/science-research/about-science-research-fda/fdas-predictive-toxicology-roadmap.
[12]
FDA.Advancing alternative methods at FDA [EB/OL].(2022-01-05)[2024-04-16].https://www.fda.gov/science-research/about-science-research-fda/advancing-alternative-methods-fda.
[13]
ADASHI E Y, O’MAHONY D P, COHEN I G.The FDA Modernization Act 2.0: drug testing in animals is rendered optional [J/OL].Am J Med, 2023, 136(9): 853-854.
[14]
EPA.Directive to prioritize efforts to reduce animal testing [EB/OL].(2019-09-10)[2024-04-16].https://www.epa.gov/sites/default/files/2019-09/documents/image2019-09-09-231249.pdf.
[15]
EMA.First EMA workshop on non-animal approaches in support of medicinal product development: challenges and opportunities for use of micro-physiological systems [EB/OL].(2017-05-10)[2024-04-16].https://www.ema.europa.eu/en/documents/report/report-first-ema-workshop-non-animal-approaches-support-medicinal-product-development-challenges_en.pdf.
[16]
PAMIES D, LEIST M, COECKE S, et al.Guidance document on Good Cell and Tissue Culture Practice 2.0(GCCP 2.0) [J].ALTEX, 2022, 39: 30-70.
[17]
HCA.New EU-funded Research Project “HCA|Organoid”: toward a single-cell atlas of human organoids for biomedical research [EB/OL].(2020-08-31)[2024-04-16].https://www.hca-organoid.eu/news/kickstarting-organoid-cell-atlas.
[18]
European Commission.Horizon Europe Health double stage calls 2024 - Unlocking the full potential of new tools, technologies and digital solutions for a healthy society(Destination 5)[EB/OL].(2023-03-30)[2024-04-16].https://hadea.ec.europa.eu/calls-proposals/horizon-europe-health-double-stage-calls-2024-unlocking-full-potential-new-tools-technologies-and_en.
[19]
MARX U, AKABANE T, ANDERSSON T B, et al.Biologyinspired microphysiological systems to advance patient benefit and animal welfare in drug development [J].ALTEX, 2020, 37(3): 365-394.
[20]
国家科学技术部.科技部关于发布国家重点研发计划“数学和应用研究”等“十四五”重点专项2021年度项目申报指南的通知[EB/OL].(2021-05-10)[2024-04-16].https://service.most.gov.cn/kjjh_tztg_all/20210510/4272.html.
[21]
国家药品监督管理局药品审评中心.基因治疗产品非临床研究与评价技术指导原则(试行)[EB/OL].(2021-12-03)[2024-04-16].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=3c3eef7964f7950ca9a18b-9ce095088c.
[22]
国家药品监督管理局药品审评中心.基因修饰细胞治疗产品非临床研究技术指导原则(试行)[EB/OL].(2021-12-03)[2024-04-16].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=b7dfbba537d5ecc30659d-715f5045acb.
[23]
类器官药物敏感性检测指导肿瘤精准治疗临床应用专家共识(2022年版)编写专家组,王树滨,高静,等.类器官药物敏感性检测指导肿瘤精准治疗临床应用专家共识(2022年版)[J].中国癌症防治杂志,2022,14(3):234-239.
[24]
中国抗癌协会肿瘤多学科诊疗专业委员会,中国抗癌协会肿瘤内分泌专业委员会,邹冬玲,等.肿瘤类器官诊治平台的质量控制标准中国专家共识(2022年版)[J].中国癌症杂志,2022,32(7):657-668.
[25]
中国细胞生物学学会.人肠癌类器官[EB/OL].(2022-09-23)[2024-04-16].http://www.ttbz.org.cn/StandardManage/Detail/67886/.
[26]
中国细胞生物学学会.人肠道类器官[EB/OL].(2022-09-23)[2024-04-16].http://www.ttbz.org.cn/StandardManage/Detail/67884/.
[27]
中国医药生物技术协会.人正常乳腺及乳腺癌类器官制备、冻存、复苏和鉴定操作指南[EB/OL].(2023-02-22)[2024-04-16].http://www.ttbz.org.cn/StandardManage/Detail/77610/.
[28]
XU R, ZHOU X, WANG S, et al.Tumor organoid models in precision medicine and investigating cancer-stromal interactions [J].Pharmacol Ther, 2021, 218: 107668.
[29]
LIU H, ZHANG Y, ZHANG Y Y, et al.Human embryonic stem cell-derived organoid retinoblastoma reveals a cancerous origin [J].Proc Natl Acad Sci U S A, 2020, 117(52): 33628-33638.
[30]
CANDIELLO J, GRANDHI T S P, GOH S K, et al.3D heterogeneous islet organoid generation from human embryonic stem cells using a novel engineered hydrogel platform [J].Biomaterials, 2018, 177: 27-39.
[31]
VARZIDEH F, PAHLAVAN S, ANSARI H, et al.Human cardiomyocytes undergo enhanced maturation in embryonic stem cell-derived organoid transplants [J].Biomaterials, 2019, 192: 537-550.
[32]
RAHMANI S, BREYNER N M, SU H M, et al.Intestinal organoids: a new paradigm for engineering intestinal epithelium in vitro [J].Biomaterials, 2019, 194: 195-214.
[33]
BAYRER J R, WANG H, NATTIV R, et al.LRH-1 mitigates intestinal inflammatory disease by maintaining epithelial homeostasis and cell survival [J].Nat Commun, 2018, 9(1): 4055.
[34]
MARTÍNEZ-SÁNCHEZ L D C, NGO P A, PRADHAN R,et al.Epithelial RAC1-dependent cytoskeleton dynamics controls cell mechanics, cell shedding and barrier integrity in intestinal inflammation [J].Gut, 2023, 72(2): 275-294.
[35]
ZUO L, KUO WT, CAO F, et al.Tacrolimus-binding protein FKBP8 directs myosin light chain kinase-dependent barrier regulation and is a potential therapeutic target in Crohn’s disease [J].Gut, 2023, 72(5): 870-881.
[36]
MITHAL A, CAPILLA A, HEINZE D, et al.Generation of mesenchyme free intestinal organoids from human induced pluripotent stem cells [J].Nat Commun, 2020, 11(1): 215.
[37]
LEE H, JUNG K B, KWON O, et al.Limosilactobacillus reuteri DS0384 promotes intestinal epithelial maturation via the postbiotic effect in human intestinal organoids and infant mice [J].Gut Microbes, 2022, 14(1): 2121580.
[38]
LULLA V, DINAN A M, HOSMILLO M, et al.An upstream protein-coding region in enteroviruses modulates virus infection in gut epithelial cells [J].Nat Microbiol, 2019, 4(2): 280-292.
[39]
LIN S C, HAGA K, ZENG X L, et al.Generation of CRISPR-Cas9-mediated genetic knockout human intestinal tissue-derived enteroid lines by lentivirus transduction and single-cell cloning [J].Nat Protoc, 2022, 17(4): 1004-1027.
[40]
DROST J, VAN BOXTEL R, BLOKZIJL F, et al.Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer [J].Science, 2017, 358(6360): 234-238.
[41]
MATANO M, DATE S, SHIMOKAWA M, et al.Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids [J].Nat Med, 2015, 21(3): 256-262.
[42]
MEAD B E, HATTORI K, LEVY L, et al.Screening for modulators of the cellular composition of gut epithelia via organoid models of intestinal stem cell differentiation [J].Nat Biomed Eng, 2022, 6(4): 476-494.
[43]
CRUZ-ACUÑA R, QUIRÓS M, FARKAS A E, et al.Synthetic hydrogels for human intestinal organoid generation and colonic wound repair [J].Nat Cell Biol, 2017, 19(11): 1326-1335.
[44]
JARDI F, KELLY C, TEAGUE C, et al.Mouse organoids as an in vitro tool to study the in vivo intestinal response to cytotoxicants [J].Arch Toxicol, 2023, 97(1): 235-254.
[45]
SUGIMOTO S, KOBAYASHI E, FUJII M, et al.An organoid-based organ-repurposing approach to treat short bowel syndrome [J].Nature, 2021, 592(7852): 99-104.
[46]
RUMSEY J W, LORANCE C, JACKSON M, et al.Classical complement pathway inhibition in a “human-on-a-chip” model of autoimmune demyelinating neuropathies [J].Adv Ther(Weinh), 2022, 5(6): 2200030.
[47]
SEO Y, BANG S, SON J, et al.Brain physiome: a concept bridging in vitro 3D brain models and in silico models for predicting drug toxicity in the brain [J].Bioact Mater, 2021, 13: 135-148.
[48]
TAN H Y, CHO H, LEE L P.Human mini-brain models [J].Nat Biomed Eng, 2021, 5(1): 11-25.
[49]
QIAN X, SONG H, MING G L.Brain organoids: advances, applications and challenges [J].Development, 2019, 146(8): dev166074.
[50]
MA C, SEONG H, LI X, et al.Human brain organoid: a versatile tool for modeling neurodegeneration diseases and for drug screening [J].Stem Cells Int, 2022, 2022: 2150680.
[51]
LESAVAGE B L, SUHAR R A, BROGUIERE N, et al.Next-generation cancer organoids [J].Nat Mater, 2022, 21(2): 143-159.
[52]
XIANG Y, TANAKA Y, PATTERSON B, et al.Fusion of regionally specified hpsc-derived organoids models human brain development and interneuron migration [J].Cell Stem Cell, 2017, 21(3): 383-398.
[53]
KIM H, KAMM R D, VUNJAK-NOVAKOVIC G, et al.Progress in multicellular human cardiac organoids for clinical applications [J].Cell Stem Cell, 2022, 29(4): 503-514.
[54]
XUAN W, TIPPARAJU S M, ASHRAF M.Transformational applications of human cardiac organoids in cardiovascular diseases [J].Front Cell Dev Biol, 2022, 10: 936084.
[55]
PRIOR N, INACIO P, HUCH M.Liver organoids: from basic research to therapeutic applications [J].Gut, 2019, 68(12): 2228-2237.
[56]
BROOKS A, LIANG X, ZHANG Y, et al.Liver organoid as a 3D in vitro model for drug validation and toxicity assessment [J].Pharmacol Res, 2021, 169: 105608.
[57]
LUO Z, ZHOU X, MANDAL K, et al.Reconstructing the tumor architecture into organoids [J].Adv Drug Deliv Rev, 2021, 176: 113839.
[58]
VENINGA V, VOEST E E.Tumor organoids: opportunities and challenges to guide precision medicine [J].Cancer Cell, 2021, 39(9): 1190-1201.
[59]
QU J, KALYANI F S, LIU L, et al.Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy [J].Cancer Commun (Lond),2021, 41(12): 1331-1353.
[60]
LOW L A, MUMMERY C, BERRIDGE B R, et al.Organs-on-chips: into the next decade [J].Nat Rev Drug Discov, 2021, 20(5): 345-361.
[61]
FDA.Advancing alternative methods at FDA [EB/OL].(2022-01-05)[2024-04-16].https://www.fda.gov/science-research/about-science-research-fda/advancing-alternative-methods-fda.
[62]
TANG X Y, WU S, WANG D, et al.Human organoids in basic research and clinical applications [J].Signal Transduct Target Ther, 2022, 7(1): 168.
[63]
MUN S J, RYU J S, LEE M O, et al.Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids [J].J Hepatol, 2019, 71(5): 970-985.
[64]
LOW J H, LI P, CHEW E G Y, et al.Generation of human PSC-derived kidney organoids with patterned nephron segments and a de novo vascular network [J].Cell Stem Cell, 2019, 25(3): 373-387.
[65]
FERRARI E, RASPONI M.Liver-Heart on chip models for drug safety [J].APL Bioeng, 2021, 5(3): 031505.
[66]
SIMMONS K T, CHAN J, HUSSAIN S, et al.Anti-C1s humanized monoclonal antibody SAR445088: a classical pathway complement inhibitor specific for the active form of C1s [J].Clin Immunol, 2023, 251: 109629.
[67]
HESPEROS.Hesperos shows potential for in vitro approach to replace conventional animal efficacy studies for rare neuromuscular disorders [EB/OL].(2022-04-19)[2024-04-16].https://hesperosinc.com/efficacy-study-for-rare-neuromuscular-disorders/.
[68]
ISOHERRANEN N, MADABUSHI R, HUANG S M.Emerging role of organ-on-a-chip technologies in quantitative clinical pharmacology evaluation [J].Clin Transl Sci, 2019, 12(2): 113-121.
[69]
WANG H, BROWN P C, CHOW E C Y, et al.3D cell culture models: drug pharmacokinetics, safety assessment, and regulatory consideration [J].Clin Transl Sci, 2021, 14(5): 1659-1680.
2024年第55卷第5期
29
6
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2024.05.004
  • 接收时间:2024-01-02
  • 首发时间:2026-11-18
  • 出版时间:2024-05-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-01-02
基金
作者信息
    1.复旦大学药学院,上海 201203
    2.复旦大学附属中山医院,上海 200032
    3.上海药品审评核查中心,上海 201203

通讯作者:

陈一飞(1983—),女,副研究员,从事GCP/GLP、药品监管科学的研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.05.004
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏